Product Description

The combination of Calcium Citrate and Calcitriol represents a sophisticated therapeutic approach to bone health, particularly for individuals with impaired renal function or those requiring high-precision mineral absorption. Calcium Citrate serves as a superior mineral source compared to calcium carbonate, as its absorption is independent of gastric pH; this makes it the preferred choice for patients using proton pump inhibitors or those with achlorhydria (low stomach acid), and it is associated with a lower incidence of nephrolithiasis (kidney stones). Calcitriol, the active hormonal form of Vitamin D3, bypasses the need for hepatic and renal hydroxylation, acting directly on the Vitamin D receptors (VDR) in the intestine to stimulate the synthesis of calcium-binding proteins (calbindins). This synergistic action ensures that the ingested calcium is actively transported across the intestinal epithelial cells and into the systemic circulation, maintaining serum calcium levels and suppressing excessive Parathyroid Hormone (PTH) secretion, which would otherwise trigger bone resorption. From a clinical standpoint, this combination is a cornerstone in the management of hypocalcemia, secondary hyperparathyroidism, and metabolic bone diseases such as osteoporosis or renal osteodystrophy. Because calcitriol is highly potent, it provides a much faster onset of action than inactive Vitamin D supplements, but it also carries a narrower therapeutic index, requiring periodic monitoring of serum calcium and phosphate levels to prevent hypercalcemia and soft tissue calcification. Unlike fat-soluble cholecalciferol, calcitriol does not require bile for absorption, making it highly effective for patients with malabsorption syndromes. To optimize safety and efficacy, clinicians often emphasize the "calcium-phosphate product" to ensure that the increased mineral absorption does not lead to vascular complications, particularly in patients with chronic kidney disease (CKD).